开发数据处理算法,以计算吸入疗法使用囊性纤维化成人的坚持 - 在CFHealthHub学习健康系统内的多中心观察研究
Robert D Sandler1,2, Lana Lai3, Sophie Dawson4
1Adult CF Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Expert review of pharmacoeconomics & outcomes research
|March 8, 2024
概括
一个新的算法从囊性纤维化患者的雾化器数据准确计算每日吸入的药物剂量. 这增强了遵守跟踪,并建立了对数字健康工具的信任.
科学领域:
- 数字健康数字健康
- 吸入药物 药物坚持 吸入药物坚持
- 囊性纤维化研究 囊性纤维化研究
背景情况:
- 准确的粘附数据对于治疗囊性纤维化 (CF) 是至关重要的.
- 电子捕获的雾化器数据为药物使用提供了客观的见解.
- 计算每日完整剂量计数的现有方法可能不准确.
研究的目的:
- 开发一个强大的算法来计算吸入药物的每日完整剂量计数.
- 在CFHealthHub学习健康系统中利用电子捕获的雾化器数据.
- 为了提高CF患者的坚持计算的准确性.
主要方法:
- 这是一项涉及参与者和临床医生的多中心,横截面研究.
- 对每日完整剂量计数的共识是通过将使用记录与雾化器数据进行三元化来建立的.
- 一个只使用客观雾化器数据的算法被开发和验证.
主要成果:
- 该算法选了无效剂量,并结合了紧密时间的剂量.
- 它表现出与参与者和临床医生的共识强烈一致.
- 卡帕系数在导出中为0.85,在验证数据集中为0.86.
结论:
- 开发的算法准确计算了每天的完整剂量计数.
- 这增强了对CFHealthHub数据和数字终点的信心.
- 发布数据处理方法可以促进对数字健康倡议的信任.
更多相关视频
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
10.7K
07:38Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
2.4K
相关概念视频
Cystic Fibrosis: Management
164
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
164
Cystic Fibrosis: Pathogenesis
239
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
239
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Inhaled Medications
258
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
258
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Pulmonary Function Tests
330
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
330
